Schedule an Appointment with U of U Health (MyChart)
If you're an existing patient of this provider, please use your U of U Health (MyChart) account to schedule your appointment.
Sign in to U of U Health (MyChart)Haven't set up a U of U Health (MyChart) account yet? Create an account
Need Assistance?
If you're having trouble signing in, need guidance on using U of U Health (MyChart), or require support with your account, please visit our FAQ page.
Clinical Locations
Specialties
Board Certification
|
American Board of Internal Medicine (Sub: Infectious Disease)
American Board of Internal Medicine (Internal Medicine)
|
Patient Rating
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
I trust Dr Spivak which makes it easy to talk to him about my health concerns.
Very knowledgeable, kind , and empathetic
Dr Adam Spivak is phenomenal
DR Adam Spivak and his other attending staff are highly recommended by me to give great care & help
Excelente doctor . Me sent muy cmodo con el .
As mentioned earlier, Dr. Spivak is great and always shows care/good beside manner.
Dr. Spivak has actually been one of my best advocates he's like a superhero he knows of my current circumstances coming out of homelessness and dealing with in State matter dealing with a Social Security matter that regards that and so he's been phenomena when he always has been as long as I've known him
This was one of the best doctor visits I have had. I felt heard and also, that the physician gave me professional care.I was very comfortable with Dr Spivak
Dr Spivak is amazing. I was recommended by a friend and have already recommended other friends.
always is very caring
Dr. Spivak no only asked me about my medical issues but showed great concern for my mental health without any judgment.
Dr Adam Spivak and the rest of his accompanying staff are amazing
Adam is a great doctor and a very nice person
Excellence on all levels
Es uno de los mejores doctores y si no creo que es el mejor doctor que me a atendido en mi proceso Muchas por su servicio doctor Adam
Top notch Specialist
Just a great doctor feels like a friend and always listen to my concerns and my life care needs
The best team
Truly an outstanding physician! He is extremely knowledgeable, genuinely cares about my health and ongoing medical issues - I have a lot.... He looks at all of my medical concerns, not just infectious disease; he understands that everything is connected and matters in the grand scheme of things. I believe that he really does care, and pays attention to all the things that matter. I could not ask for a better physician. He's truly one of the best! - Dana W.
Dr. Spivak was incredible and super friendly.He was incredibly informative and made sure I understood everything that was going on.
Dr. Spivak is great! He always takes the time to make sure I understand and explains everything in great detail. He answers all my questions. I would highly recommend him to anyone seeking HIV care.
Amen
Friendly and professional
Dr. Spivak has such an easy going demeaner. He has an ability to put you at ease and make you comfortable asking any questions you may have. I have always seen him at the end of the day and he is never in a hurry to rush through the appointment. There is a way about him that is genuine and caring and inviting.
Dr. Spivak was exceptional. He took extra time to listen and explain. I felt very comfortable and confident with him.
I have already recommended the provider multiple times. They make access very easy, and still spend the time to answer questions. Unlike several doctored that you feel like a dollar sign I feel like my care is about me and not money.
great doctor
The best! He is amazing Doc Spivak, Christine and Mark Young are life savers.
I loved Dr. Spivak (or however you spell his name). He is very friendly and likes to talk (in a good way).
He's very professional, very good at what he does. He speaks to you and treats you with respect. He's a good listener and cares about his patients. [TRANSLATED]
Doing a great job!
Es muy profesional, amable, educado y respetuoso.
Dr. Spivak is thorough and easy to talk with.
Dr. Spivak was 100% the right choice for my care. Very easy to talk with, listened to my concerns, and not bad on the eyes!
Provider remembered me and the discussion from the last visit. He carefully went over the next step and plan. They automatically set up my next three month appointment.
Dr. Spivak was very professional, approachable, more than generous with the amount of time that was spent with me and explained my options and answered my questions in a way that was very easy to understand. I felt very relaxed throughout the vist.
borh dr Spivak and Christine e so kind and caring
Dr Adam Spivak is phenomenal, I'm so grateful that he is caring for me in my health conditions
He's awesome, always patient-focused, letting us know about the progress on our medications¿
They put a lot of traffic on me and made me feel like a beggar. [TRANSLATED]
He's great.
A very kind and thoughtful Doctor. He takes his profession into high level by communicating with me very thoroughly and great bedside manner is great
This feedback includes Christine Jamjian. She is the best pharmacist I've known . She is opened to questions and give positive feedback and answers. She's also knowledgeable and adds me on her decisions. I really trust her
Dr. Spivak was thorough and kind. He listened to me and was empathetic and compassionate. I would highly recommend him.
Dr Adam Spivak is just phenomenal
I feel extremely confident in the care I get through Clinic 1A - this includes the doctors, nurses, pharmacy team, advocates and front desk check-in personnel.
Dr. Spivak is warm and engaging. He is also very flexible to my needs.
Caring doctor who works hard treat patients with kindness and dignity.
Excellent care! Great bedside manner. He is a good communicator and very kind and excellent in his specialties.
My relationship with Dr. Spivak have been a delightful experience. I consider Him like my Family whom I Cherish
Dr. Spivak was great. He listened to me carefully, prompted me with questions about my sexual health and PrEP needs, and helped set up a treatment plan to make sure I had coverage right away.
El Dr. Adam M. Spivak es una persona muy humanista, cordial, atento con sus pacientes y muy profesional. Estoy muy agradecido con usted.
Dr. Spivak is both knowledgeable and caring. I always have a lot of questions when it comes to my health and he takes the time to listen and answer them in a way I understand. He is easy to talk to about sensitive topics and truly cares.
Adam is what I would call a patient's doctor as opposed to a doctor's doctor. He listens to what you are saying and provides usable feedback. He talks with you - not at you. Because of this I trust he actually cares about me as a person.
He has been my doctor for 7 years, could not feel better cared for
Dr. Spivak does an amazing job at making uncomfortable conversations extremely comfortable and easy.
Care provider is always on quest for the best solution for me.
He is very good at explaining everything.
Dr Spivak was awesome! He spent extra time getting to know me and sharing what is coming down the pipeline for my treatment. He really took an interest in me as a patient. I left with a feeling of hope and excitement for the future. This is something I have never had before in the 15+ years of treatment. He listened to my concerns and addressed each one of them. I think this is going to be a great fit for my healthcare team. I would highly recommend him to anyone.
Wonderful person.
Dr Adam Spivak is a brilliant man and he cares so much about everybody words can't express how much I respect and love this Dr he is the absolute greatest man I've ever met. Utah is so lucky to have him.
Doctor Spivak was very personable, friendly. He spent all the time needed to confer with me and explain his thoughts regarding my health. As this was my first visit with him as a new patient, he was very thoughtful and took time to understand my desires for health care. He is a great guy.
He is the only Dr. I saw and he was very caring and helpful.
Dr. Spivak is the best. He genuinely cares about me as a person and a patient. He understands my situation, and works to find the best possible solution to accommodate all of my needs and situations. I trust and admire everything he does for me.
Great bedside manner, very thorough and listens to my concerns. He is very accommodating and also promptly answer my messages instead of his assistant. He also spend his time explaining things and his team are professionals yet very kind. I would recommend him a 100%.
Excellent and knowledgeable Dr. and easy to talk to.
I trust all the medical professionals at the Infectious disease clinic. I always feel they are invested in seeing that I get the best health outcome possible.
Looking forward to continuing with great care.
Haven't yet had a one on one appointment with him
He is a knowledgeable and caring physician. He is always willing to answer all my questions and gives me options for my health care
He was very kind, like the previous appointments I've had. Excellent. [TRANSLATED]
Dr. Spivak is one of a kind in His Specialty. He's a very compassionate being doing His best in His Field of expertise. Give this Man a substantial raise because it's not for the weakhearted
Dr Spivak is above and beyond, he's super kind and professional
I enjoyed my visit with Dr. Spivak. He is kind, articulate and attentive in regards to my health care issues. I trust him and it was easy to relate to his exceptional caring demeanor!
Most intelligent doctor I've ever met outstanding personality extremely nice I have been under his care for 12 years. He's the best!!
He is very kind [TRANSLATED]
have not seen him yet but my intake was very good
Amazing provider
Honor to meet Mr. Adam M. Spivak, MD, knowledgeable in his medical profession.
I appreciate your kind attention and service towards me. [TRANSLATED]
Dr. Spivak is king and genuinely cares about me as a patient.
Dr. Adam Spivak is the quintessential physician in that his approach is balanced with both knowledge and care. He is a very good Doctor.
with the student doctor I dont feel like Im being heard and she talks down to me. Then she reports to Dr Spivak but by the time he gets involve Im ready to leave.
Board Certification and Academic Information
| Academic Departments |
Internal Medicine
-Associate Professor Pathology -Adjunct Assistant Professor |
|---|---|
| Academic Divisions |
Infectious Diseases
|
| Board Certification |
American Board of Internal Medicine (Sub: Infectious Disease)
American Board of Internal Medicine (Internal Medicine)
|
Education history
| Undergraduate | English Literature - Princeton University | A.B. |
|---|---|---|
| Professional Medical | Medicine - University of Maryland School of Medicine | M.D. |
| Internship | Internal Medicine - Johns Hopkins University School of Medicine | Intern |
| Residency | Internal Medicine - Johns Hopkins University School of Medicine | Resident |
| Chief Resident | Internal Medicine - Johns Hopkins University School of Medicine | Chief Resident |
| Fellowship | Infectious Diseases - Johns Hopkins University School of Medicine | Fellow |
Selected Publications
Journal Article
- Spivak AM, Bosque A, Balch AH, Smyth D, Martins L, Planelles V (2015). Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients. Antimicrob Agents Chemother, 59(10), 5984-91.
- Spivak AM, Nell RA, Petersen M, Martins L, Sebahar P, Looper RE, Planelles V (2018). Synthetic Ingenols Maximize Protein Kinase C-Induced HIV-1 Latency Reversal. Antimicrob Agents Chemother, 62(11).
- Sorensen ES, Macedo AB, Resop RS, Howard JN, Nell R, Sarabia I, Newman D, Ren Y, Jones RB, Planelles V, Spivak AM, Bosque A (2020). Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing Agents. Antimicrob Agents Chemother, 64(8).
- Spivak AM, Andrade A, Eisele E, Hoh R, Bacchetti P, Bumpus NN, Emad F, Buckheit R 3rd, McCance-Katz EF, Lai J, Kennedy M, Chander G, Siliciano RF, Siliciano JD, Deeks SG (2014). A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy. Clin Infect Dis, 58(6), 883-90.
- Spivak AM, Rabi SA, McMahon MA, Shan L, Sedaghat AR, Wilke CO, Siliciano RF (2011). Short communication: dynamic constraints on the second phase compartment of HIV-infected cells. AIDS Res Hum Retroviruses, 27(7), 759-61.
- Martins LJ, Bonczkowski P, Spivak AM, De Spiegelaere W, Novis CL, DePaula-Silva AB, Malatinkova E, Trypsteen W, Bosque A, Vanderkerckhove L, Planelles V (2016). Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus. AIDS Res Hum Retroviruses, 32(2), 187-93.
- Macedo AB, Resop RS, Martins LJ, Szaniawski MA, Sorensen ES, Spivak AM, Nixon DF, Jones RB, Planelles V, Bosque A (2018). Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus. AIDS Res Hum Retroviruses, 34(9), 769-777.
- Pan F, Xiao X, Guo J, Song Y, Li H, Patel DP, Spivak AM, Alukal JP, Zhang X, Xiong C, Li PS, Hotaling JM (2020). No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019. Fertil Steril, 113(6), 1135-1139.
- Szaniawski MA, Spivak AM, Bosque A, Planelles V (2018). Sex Influences SAMHD1 Activity and Susceptibility to Human Immunodeficiency Virus-1 in Primary Human Macrophages. J Infect Dis, 219(5), 777-785.
- Spivak AM, Salgado M, Rabi SA, O'Connell KA, Blankson JN (2011). Circulating monocytes are not a major reservoir of HIV-1 in elite suppressors. J Virol, 85(19), 10399-403.
- Dinoso JB, Kim SY, Wiegand AM, Palmer SE, Gange SJ, Cranmer L, O'Shea A, Callender M, Spivak A, Brennan T, Kearney MF, Proschan MA, Mican JM, Rehm CA, Coffin JM, Mellors JW, Siliciano RF, Maldarelli F (2009). Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci U S A, 106(23), 9403-8.
- Weil AF, Ghosh D, Zhou Y, Seiple L, McMahon MA, Spivak AM, Siliciano RF, Stivers JT (2013). Uracil DNA glycosylase initiates degradation of HIV-1 cDNA containing misincorporated dUTP and prevents viral integration. Proc Natl Acad Sci U S A, 110(6), E448-57.
- Abdel-Mohsen M, Richman D, Siliciano RF, Nussenzweig MC, Howell BJ, Martinez-Picado J, Chomont N, Bar KJ, Yu XG, Lichterfeld M, Alcami J, Hazuda D, Bushman F, Siliciano JD, Betts MR, Spivak AM, Planelles V, Hahn BH, Smith DM, Ho YC, Buzon MJ, Gaebler C, Paiardini M, Li Q, Estes JD, Hope TJ, Kostman J, Mounzer K, Caskey M, Fox L, Frank I, Riley JL, Tebas P, Montaner LJ, BEAT-HIV Delaney Collaboratory to Cure HIV-1 infection. (2020). Recommendations for measuring HIV reservoir size in cure-directed clinical trials. Nat Med, 26(9), 1339-1350.
- Gaillard S, Dinoso JB, Marsh JA, DeZern AE, O'Connell KA, Spivak AM, Alwood K, Durand CM, Ambinder RF, Blankson JN (2011). Sustained elite suppression of replication competent HIV-1 in a patient treated with rituximab based chemotherapy. J Clin Virol, 51(3), 195-8.
- Pradilla G, Nagahama Y, Spivak AM, Bydon A, Rigamonti D (2010). Spinal epidural abscess: current diagnosis and management. Curr Infect Dis Rep, 12(6), 484-91.
- Spivak AM, Larragoite ET, Coletti ML, Macedo AB, Martins LJ, Bosque A, Planelles V (2016). Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo. Retrovirology, 13(1), 88.
- Zheng Y, Larragoite ET, Williams ESCP, Lama J, Cisneros I, Delgado JC, Slev P, Rychert J, Innis EA, Coiras M, Rondina MT, Spivak AM, Planelles V (2021). Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions. Virol J, 18(1), 1.
- Rodríguez-Mora S, Spivak AM, Szaniawski MA, López-Huertas MR, Alcamí J, Planelles V, Coiras M (2019). Tyrosine Kinase Inhibition: a New Perspective in the Fight against HIV. Curr HIV/AIDS Rep, 16(5), 414-422.
- Pache L, Dutra MS, Spivak AM, Marlett JM, Murry JP, Hwang Y, Maestre AM, Manganaro L, Vamos M, Teriete P, Martins LJ, König R, Simon V, Bosque A, Fernandez-Sesma A, Cosford ND, Bushman FD, Young JA, Planelles V, Chanda SK (2015). BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency. Cell Host Microbe, 18(3), 345-53.
- Schynkel T, Szaniawski MA, Spivak AM, Bosque A, Planelles V, Vandekerckhove L, Trypsteen W (2020). Interferon-Mediated Long Non-Coding RNA Response in Macrophages in the Context of HIV. Int J Mol Sci, 21(20).
- Abdel-Mohsen M, Kuri-Cervantes L, Grau-Exposito J, Spivak AM, Nell RA, Tomescu C, Vadrevu SK, Giron LB, Serra-Peinado C, Genescà M, Castellví J, Wu G, Del Rio Estrada PM, González-Navarro M, Lynn K, King CT, Vemula S, Cox K, Wan Y, Li Q, Mounzer K, Kostman J, Frank I, Paiardini M, Hazuda D, Reyes-Terán G, Richman D, Howell B, Tebas P, Martinez-Picado J, Planelles V, Buzon MJ, Betts MR, Montaner LJ (2018). CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Sci Transl Med, 10(437).
- Reeves DB, Duke ER, Wagner TA, Palmer SE, Spivak AM, Schiffer JT (2018). A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation. Nat Commun, 9(1), 4811.
- Szaniawski MA, Spivak AM, Cox JE, Catrow JL, Hanley T, Williams ESCP, Tremblay MJ, Bosque A, Planelles V (2018). SAMHD1 Phosphorylation Coordinates the Anti-HIV-1 Response by Diverse Interferons and Tyrosine Kinase Inhibition. mBio, 9(3).
- Garrido C, Spivak AM, Soriano-Sarabia N, Checkley MA, Barker E, Karn J, Planelles V, Margolis DM (2016). HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function. Front Immunol, 7, 356.
- Sarabia I, Novis CL, Macedo AB, Takata H, Nell R, Kakazu JC, Furler RL, Shakya B, Schubert HL, Hill CP, DePaula-Silva AB, Spivak AM, Trautmann L, Planelles V, Bosque A (2021). Activation of the Anti-Oxidative Stress Response Reactivates Latent HIV-1 Through the Mitochondrial Antiviral Signaling Protein Isoform MiniMAVS. Front Immunol, 12, 682182.
- Bosque A, Nilson KA, Macedo AB, Spivak AM, Archin NM, Van Wagoner RM, Martins LJ, Novis CL, Szaniawski MA, Ireland CM, Margolis DM, Price DH, Planelles V (2017). Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation. Cell Rep, 18(5), 1324-1334.
- Gibson EG, Pender M, Angerbauer M, Cook C, Jones B, Spivak AM, Spivak ES, Swaminathan S (2021). Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis. Open Forum Infect Dis, 8(7), ofab176.
- Macedo AB, Novis CL, De Assis CM, Sorensen ES, Moszczynski P, Huang SH, Ren Y, Spivak AM, Jones RB, Planelles V, Bosque A (2018). Dual TLR2 and TLR7 agonists as HIV latency-reversing agents. JCI Insight, 3(19).
- Luetkens T, Metcalf R, Planelles V, Zheng Y, Larragoite ET, Spivak ES, Spivak AM, Steinbach M, Blaylock RC, Avila SV, Hankey KG, Martins TB, Slev PR, Mannuel HD, Sajadi M, Rapoport AP, Atanackovic D (2020). Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19. Blood Adv, 4(19), 4864-4868.
- Trivedi S, Afroz T, Bennett MS, Angell K, Barros F, Nell RA, Ying J, Spivak AM, Leung DT (2021). Diverse Mucosal-Associated Invariant TCR Usage in HIV Infection. Immunohorizons, 5(5), 360-369.
- Pache L, Marsden MD, Teriete P, Portillo AJ, Heimann D, Kim JT, Soliman MSA, Dimapasoc M, Carmona C, Celeridad M, Spivak AM, Planelles V, Cosford NDP, Zack JA, Chanda SK (2020). Pharmacological Activation of Non-canonical NF-¿B Signaling Activates Latent HIV-1 Reservoirs In Vivo. Cell Rep Med, 1(3), 100037.
- Redecke V, Tawaratsumida K, Larragoite ET, Williams ESCP, Planelles V, Spivak AM, Hirayama L, Elgort M, Swenson S, Smith R, Worthen B, Zimmerman R, Slev P, Cahoon B, Astill M, Häcker (2021). A rapid and affordable point of care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial intelligence interpretation. Scientific reports, 11(1), 24507.
- Larragoite ET, Nell RA, Martins LJ, Barrows LR, Planelles V, Spivak A (2022). Histone deacetylase inhibition reduces deleterious cytokine release induced by ingenol stimulation. Biochemical pharmacology, 195, 114844.
- Innis EA, Levinger C, Szaniawski MA, Williams ESCP, Alcamí J, Bosque A, Schiffer JT, Coiras M, Spivak AM, Planelles (2021). Pharmacologic control of homeostatic and antigen-driven proliferation to target HIV-1 persistence. Biochemical pharmacology, 194, 114816.
- Tsai YC, Nell RA, Buckendorf JE, Kúsz N, Mwangi PW, Berkecz R, Rédei D, Vasas A, Spivak AM, Hohmann (2021). Bioactive Compounds from Euphorbia usambarica Pax. with HIV-1 Latency Reversal Activity. Pharmaceuticals (Basel, Switzerland), 14(7),
- Rodríguez-Mora S, Sánchez-Menéndez C, Bautista-Carrascosa G, Mateos E, Moreno-Serna L, Megías D, Cantón J, García-Gutiérrez V, Murciano-Antón MA, Cervero M, Spivak A, Planelles V, Coiras (2024). Dasatinib interferes with HIV-1 proviral integration and the inflammatory potential of monocyte-derived macrophages from people with HIV. Biochemical pharmacology, 229, 116512.
- Manzanares M, Ramos-Martín F, Rodríguez-Mora S, Casado-Fernández G, Sánchez-Menéndez C, Simón-Rueda A, Mateos E, Cervero M, Spivak AM, Planelles V, Torres M, García-Gutiérrez V, Coiras (2024). Sustained antiviral response against in vitro HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinib. Frontiers in pharmacology, 15, 1426974.
- Ho TF, Zenger B, Mark B, Hiatt L, Sullivan E, Steinberg BA, Lyons A, Spivak AM, Agarwal C, Adelman M, Hotaling J, Kiraly B, Talboys (2024). Characteristics of a transgender and gender-diverse patient population in Utah: Use of electronic health records to advance clinical and health equity research. PloS one, 19(5), e0302895.
- Gillis N, Dickey BL, Colin-Leitzinger C, Tang YH, Putney RM, Mesa TE, Yoder SJ, Suneja G, Spivak AM, Patel AB, Extermann M, Giuliano AR, Teng M, Kresovich J, Berglund A, Coghill A (2024). Clonal Hematopoiesis in Patients With Human Immunodeficiency Virus and Cancer. The Journal of infectious diseases, 230(3), 680-688.
- Ravkov EV, Williams ESCP, Elgort M, Barker AP, Planelles V, Spivak AM, Delgado JC, Lin L, Hanley T (2024). Reduced monocyte proportions and responsiveness in convalescent COVID-19 patients. Frontiers in immunology, 14, 1329026.
- Dickey BL, Putney RM, Suneja G, Kresovich JK, Spivak AM, Patel AB, Teng M, Extermann M, Giuliano AR, Gillis N, Berglund A, Coghill A (2023). Differences in epigenetic age by HIV status among patients with a non-AIDS defining cancer. AIDS (London, England), 37(13), 2049-2057.
- Reiersen AM, Mattar C, Bender Ignacio RA, Boulware DR, Lee TC, Hess R, Lankowski AJ, McDonald EG, Miller JP, Powderly WG, Pullen MF, Rado JT, Rich MW, Schiffer JT, Schweiger J, Spivak AM, Stevens A, Vigod SN, Agarwal P, Yang L, Yingling M, Gettinger TR, Zorumski CF, Lenze E (2023). The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial. Open forum infectious diseases, 10(8), ofad419.
- Spivak AM, Barney BJ, Greene T, Holubkov R, Olsen CS, Bridges J, Srivastava R, Webb B, Sebahar F, Huffman A, Pacchia CF, Dean JM, Hess (2023). A Randomized Clinical Trial Testing Hydroxychloroquine for Reduction of SARS-CoV-2 Viral Shedding and Hospitalization in Early Outpatient COVID-19 Infection. Microbiology spectrum, 11(2), e0467422.
- Mitjà O, Reis G, Boulware DR, Spivak AM, Sarwar A, Johnston C, Webb B, Hill MD, Smith D, Kremsner P, Curran M, Carter D, Alexander J, Corbacho M, Lee TC, Hullsiek KH, McDonald EG, Hess R, Hughes M, Baeten JM, Schwartz I, Metz L, Richer L, Chew KW, Daar E, Wohl D, Dunne (2023). Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials. Clinical and translational science, 16(3), 524-535.
- Cruz-Lorenzo E, Ramirez NP, Lee J, Pandhe S, Wang L, Hernandez-Doria J, Spivak AM, Planelles V, Petersen T, Jain MK, Martinez ED, D'Orso (2022). Host Cell Redox Alterations Promote Latent HIV-1 Reactivation through Atypical Transcription Factor Cooperativity. Viruses, 14(10),
- Williams ES, Martins TB, Shah KS, Hill HR, Coiras M, Spivak AM, Planelles (2022). Cytokine Deficiencies in Patients with Long-COVID. Journal of clinical & cellular immunology, 13(6),
- Williams ESCP, Szaniawski MA, Martins LJ, Innis EA, Alcamí J, Hanley TM, Spivak AM, Coiras M, Planelles (2022). Dasatinib: effects on the macrophage phospho proteome with a focus on SAMHD1 and HIV-1 infection. Clinical research in HIV/AIDS, 8(1),
Review
- Spivak AM, Planelles V (2018). Novel Latency Reversal Agents for HIV-1 Cure. [Review]. Annu Rev Med, 69, 421-436.
- Barber AE, Norton JP, Spivak AM, Mulvey MA (2013). Urinary tract infections: current and emerging management strategies. [Review]. Clin Infect Dis, 57, (5), 719-24.
- Spivak AM, Sydnor ER, Blankson JN, Gallant JE (2010). Seronegative HIV-1 infection: a review of the literature. [Review]. AIDS, 24, (10), 1407-14.
- Spivak AM, Planelles V (2016). HIV-1 Eradication: Early Trials (and Tribulations). [Review]. Trends Mol Med, 22, (1), 10-27.
- Szaniawski MA, Spivak AM (2020). Senotherapeutics and HIV-1 Persistence. [Review]. Curr HIV/AIDS Rep, 17, (3), 219-225.
- Szaniawski MA, Spivak AM (2020). Senotherapeutics for HIV and aging. [Review]. Curr Opin HIV AIDS, 15, (2), 83-93.
Book
- Spivak A (2008). Harrison's Principles of Internal Medicine Self-Assessment & Board Review. [contributing editor].
Book Chapter
- Spivak A, Zaas A, Cheng A, Auwaerter (2006). CNS Infections.
- Spivak A, Sosnay P, Cosgrove (2006). Soft Tissue and Bone Infection.
Commentary
- Larragoite ET, Spivak AM (2019). Down but not out. Elife, 8.
Case Report
- Vargas JD, Spivak AM (2009). A perfect storm. Gastric bezoar. Am J Med, 122(6), 519-21.
- Spivak AM, Brennan TP, O'Connell KA, Sydnor E, Williams TM, Siliciano RF, Gallant JE, Blankson JN (2010). A case of seronegative HIV-1 infection. J Infect Dis, 201(3), 341-5.
- Rodriguez ED, Bluebond-Langner R, Spivak AM, Eisig SB (2007). Surgical management of maxillofacial uremic osteodystrophy: a case report. J Oral Maxillofac Surg, 65(9), 1825-9.
- Rachakonda T, Kendall B, Spivak AM, Boltax J (2017). Pleural Effusion Caused by Bacillus Calmette-Guérin Immunotherapy for Bladder Cancer. Open Forum Infect Dis, 4(3), ofx126.
- Johnson RA, Spivak AM (2017). Lues Maligna. Open Forum Infect Dis, 4(3), ofx139.
- Szaniawski MA, Spivak AM (2019). Recurrent Paenibacillus infection. Oxf Med Case Reports, 2019(5), omz034.
Letter
- Spivak AM, Siliciano RF (2010). Using highly active antiretroviral therapy to decrease perioperative HIV-1 transmission risk. [Letter to the editor]. AIDS, 24(10), 1603-4; author reply 1604.